Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
29.06
-0.09 (-0.31%)
Dec 24, 2024, 1:00 PM EST - Market closed
Collegium Pharmaceutical Employees
Collegium Pharmaceutical had 197 employees as of December 31, 2023. The number of employees decreased by 10 or -4.83% compared to the previous year.
Employees
197
Change (1Y)
-10
Growth (1Y)
-4.83%
Revenue / Employee
$3,041,853
Profits / Employee
$449,716
Market Cap
937.19M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
The Pennant Group | 5,791 |
HealthStream | 1,092 |
Adaptive Biotechnologies | 709 |
Poseida Therapeutics | 330 |
Liquidia | 145 |
89bio | 70 |
COLL News
- 4 weeks ago - Collegium Pharmaceutical: Strong Growth With Pain Management And ADHD Expansion - Seeking Alpha
- 5 weeks ago - Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD) - GlobeNewsWire
- 6 weeks ago - Collegium Pharmaceutical, Inc. (COLL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Collegium Reports Record Third Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - Collegium Pharmaceutical, Inc. (COLL) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Collegium Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 5 months ago - Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology - GlobeNewsWire